Genomed S.A. will present its offer of diagnostics tests, as well as results of its R&D activities, during the 52nd Annual Conference of the European Society of Human Genetics (ESHG 2018) in Milan, Italy, that will be held on June 16-19, 2018.
Traditionally, during the conference, the most recent achievements in all areas of research of human genetics are presented. Genomed team will present results of the project ‘Innovative strategy for diagnostics, prevention and adiuvant therapy of selected neurodegenerative disorders in population of Polish ancestry’, implemented as a part of the STRATEGMED programme.
As part of the presentation of the latest offer of diagnostic tests and NGS services offered by Genomed SA, new diagnostic panels, developed by the Genomed team, will be presented, including an ophthalmic panel for retinal degenerative diseases and cancer panels for somatic mutations, as well as assumptions, goals and first results of a project aimed at advancement of non-invasive genetic diagnostics of cancer - liquid biopsy (project no. RPMA.01.02.00-14-6209: ‘Development of methods of non-invasive genetic diagnostics and cancer prevention - liquid biopsy’ co-financed from the European Union funds under the European Regional Development Fund). The Genomed team will also present its current offer of whole genome sequencing (WGS), in the clinical and preventive applications.
This most important conference in the field of human genetics in Europe gathers over 3,000 representatives of the world of science and medicine, including delegates from all European Genetic Societies. During the conference, the latest discoveries in the field of human genetics will be presented, both in the field of basic and applied research. Almost 100 lecturers from various countries confirmed their participation in the conference. About 250 oral speeches, over a dozen thematic workshops and educational sessions are planned. More than 160 exhibitors - the most important and innovative companies from all over the world - will present their new products.
We cordially invite participants of the ESHG Conference to the booth #610, where the CEO of Genomed S.A., Dr. Anna Boguszewska-Chachulska and director of the diagnostic laboratory Dr. Monika Jurkowska will be available. We also invite you to get acquainted with the conference presentation: "hole exome sequencing of a cohort of Polish patients with retinal disorders - NeuStemGen project" (poster no.: 2018-A-472-ESHG).
Traditionally, during the conference, the most recent achievements in all areas of research of human genetics are presented. Genomed team will present results of the project ‘Innovative strategy for diagnostics, prevention and adiuvant therapy of selected neurodegenerative disorders in population of Polish ancestry’, implemented as a part of the STRATEGMED programme.
As part of the presentation of the latest offer of diagnostic tests and NGS services offered by Genomed SA, new diagnostic panels, developed by the Genomed team, will be presented, including an ophthalmic panel for retinal degenerative diseases and cancer panels for somatic mutations, as well as assumptions, goals and first results of a project aimed at advancement of non-invasive genetic diagnostics of cancer - liquid biopsy (project no. RPMA.01.02.00-14-6209: ‘Development of methods of non-invasive genetic diagnostics and cancer prevention - liquid biopsy’ co-financed from the European Union funds under the European Regional Development Fund). The Genomed team will also present its current offer of whole genome sequencing (WGS), in the clinical and preventive applications.
This most important conference in the field of human genetics in Europe gathers over 3,000 representatives of the world of science and medicine, including delegates from all European Genetic Societies. During the conference, the latest discoveries in the field of human genetics will be presented, both in the field of basic and applied research. Almost 100 lecturers from various countries confirmed their participation in the conference. About 250 oral speeches, over a dozen thematic workshops and educational sessions are planned. More than 160 exhibitors - the most important and innovative companies from all over the world - will present their new products.
We cordially invite participants of the ESHG Conference to the booth #610, where the CEO of Genomed S.A., Dr. Anna Boguszewska-Chachulska and director of the diagnostic laboratory Dr. Monika Jurkowska will be available. We also invite you to get acquainted with the conference presentation: "hole exome sequencing of a cohort of Polish patients with retinal disorders - NeuStemGen project" (poster no.: 2018-A-472-ESHG).